Description of Research Expertise:
Scleroderma and related diseases clinical outcomes, therapeutic interventions and disease pathogenesis. Systemic Lupus Erythematosus clinical outcomes.
Selected Publications:
Hsu VM, Chung L, Hummers LK, Shah A, Simms R, Bolster M, Hant FN, Silver RM, Fischer A, Hinchcliff ME, Varga J, Goldberg AZ, Derk CT, Schiopu E, Khanna D, Shapiro LS, Domscic RT, Medsger T, Mayes MD, Furst D, Csuka ME, Molitor JA, Saketkoo LA, Salazar CR, Steen VD: Risk factors for mortality and cardiopulmonary hospitalization in systemic sclerosis patients at risk for pulmonary hypertension, in the PHAROS registry J Rheumatol 46 (2): 2019.
Kolstad KD, Li S, Steen V, Chung L, PHAROS Investigators: Long-term outcome in systemic sclerosis-associated pulmonary arterial hypertension from the pulmonary hypertension assessment and recognition of outcomes on scleroderma registry (PHAROS) Chest 154 (4): 2018.
Gourth P, Remmers EF, Boyden SE, Alexander T, Morgan ND, Shah AA, Mayes MD, Doumatey A, Bentley AR, Shriner D, Domsic RT, Medsger TA, Steen VD, Ramos PS, Silver RM, Korman B, Varga J, Schiopu E, Khanna D, Hsu V, Gordon JK, Saketkoo LA, Gladue H, Kron B, Criswell LA, DERK CT, Bridges SL, Shanmugam VK, Kolstad KD, Chung L, Jan R, Bernestin EJ, Goldberg A, Trojanowski M, Kafaja S, Maksimowicz-McKinnon KM, Mullikin JC, Adeyemo A, Rotimi C, Boin F, Kastner DL, Wigley FM: Brief report: Whole-Exome sequencing to identify rare variants and gene networks that increase susceptibility to scleroderma in African Americans Arthritis Rheumatol 70 (10): 1654-60,2018.
Poudel DR, Derk CT: Mortality and survival in systemic sclerosis: a review of recent literature Curr Opin Rheumatol 30 (6): 2018.
Ram Poudel D, George M, Dhital R, Karmacharya P, Sandorfi N, Derk CT: Mortality, length of stay and cost of hospitalization among patients with systemic sclerosis: results from the National Inpatient Sample Rheumatology 57 (9): 2018.
Schorpion A, Shenin M, Neubauer R, Derk CT: A prospective, open-label, non-comparative study of ambrisentan with anti-fibrotic agent combination therapy in the treatment of diffuse systemic sclerosis BMC Rheumatol : 2018.
Hosoya H, Derk CT: Clinically symptomatic pericardial effusions in hospitalized systemic sclerosis patients: Demographics and Management Biomed Res Int : 2018.
Morgan ND, Shah AA, Mayes MD, Domsic RT, Medsger TA, Steen VD, Varga J, Carns M, Ramos PS, Silver RM, Schiopu E, Khanna D, Hsu V, Gordon JK, Gladue H, Saketkoo LA, Criswell LA, Derk CT, Trojanowski MA, Shanmugam VK, Chung L, Valenzuela A, Jan R, Goldberg A, Remmers EF, Kastner DL, Wigley FM, Gourh P, Boin F: Clinical and serological features of systemic sclerosis in a multicenter African American cohort: Analysis of the genome research in African American scleroderma patients clinical database Medicine 96 (51): e8980,2017.
Poudel DR, Jayakumar D, Danve A, Sehra ST, Derk CT: Determinants of mortality in systemic sclerosis: a focused review Rheumatol Int : 1-12,2017.
Chung L, Fairchild RM, Furst DE, Li S, Alkassab F, Bolster MB, Csuka ME, Derk CT, Domsick RT, Fischer A, Frech T, Gomberg-Maitland M, Gordon JK, Hitchcliff M, Hsu V, Hummers LK, Khanna D, Medsger TA, Molitor JA, Preston IR, Schiopu E, Shapiro L, Hant F, Silver R, Simms R, Varga J, Steen VD, Zamanian RT: Utility of B-type natriuretic peptides in the assessment of patients with systemic sclerosis-associated pulmonary hypertension in the PHAROS registry Clin Exp Rheumatol 35 Suppl; 106 (4): 106-113,2017.
View all publications